Interleukin-6 (IL-6) is a pleiotropic cytokine that activates a classic signalling pathway upon
binding to its membrane-bound receptor (IL-6R). Alternatively, IL-6 may 'trans-signal'in a …

Simple Summary Laryngeal cancer represents one of the most common head and neck
cancers worldwide. It can arise in different larynx subsites, each associated with specific …

Background Previous studies that were based primarily on small numbers of patients
suggested that certain circulating proinflammatory cytokines may be associated with lung …

Li Y, Chen G, Han Z, Cheng H, Qiao L, Li Y. Onco Targets Ther. 2020; 13: 9721–9730. The
Editor and Publisher of OncoTargets and Therapy wish to retract the published article …

Recent studies have revealed that cancer cells are exacerbated by chronic inflammation.
The present study examined the immunohistochemical expression for interleukin-6 (IL-6), a …

The challenge of wound healing, particularly in patients with comorbidities such as diabetes,
is intensified by wound infection and the accelerating problem of bacterial resistance to …

Abstract Interleukin-6 (IL-6) is a proinflammatory cytokine which plays an important role in
several regulatory mechanisms of cancer. Moreover, experimental and clinical studies have …

Interleukin-6 (IL-6) is a pleiotropic cytokine which plays an important role in a number of
cellular processes including proliferation, survival, differentiation, migration and invasion. IL …

Increased expression of interleukin 6 (IL-6) is associated with poor prognosis and
chemoresistance in many different carcinomas, but its role in head and neck squamous cell …

Purpose Epidemiologic findings are inconsistent concerning the associations between C-
reactive protein (CRP), interleukin 6 (IL-6) and lung cancer risk. We conducted a meta …